Literature DB >> 2964627

[Lithium-converting enzyme inhibitors: a combination to avoid?].

M Mahieu, E Houvenagel, J J Leduc, P Choteau.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2964627

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


× No keyword cloud information.
  5 in total

Review 1.  Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

Review 2.  Pharmacokinetic drug interactions with ACE inhibitors.

Authors:  H Shionoiri
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

Review 3.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

4.  Ramipril-induced decrease in renal lithium excretion in the rat.

Authors:  M Barthelmebs; M Grima; J L Imbs
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

Review 5.  Drug Interactions with Lithium: An Update.

Authors:  Patrick R Finley
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.